Key terms
About KZIA
Kazia Therapeutics Ltd. is a clinical stage oncology company, which engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KZIA news
Mar 21
8:55am ET
Kazia Therapeutics licenses paxalisib to Sovargen
Feb 23
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 21
7:34am ET
Kazia announces early conclusion of two-part Phase I trial evaluating paxalisib
Jan 31
6:04am ET
Kazia Therapeutics files to sell 4.76M ADSs for holders
No recent press releases are available for KZIA
KZIA Financials
Key terms
Ad Feedback
KZIA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KZIA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range